Management of Chronic Lymphocytic Leukaemia
- 1 January 2000
- journal article
- review article
- Published by Springer Nature in Drugs & Aging
- Vol. 16 (1) , 9-27
- https://doi.org/10.2165/00002512-200016010-00002
Abstract
No abstract availableKeywords
This publication has 172 references indexed in Scilit:
- Autologous blood cell transplantation in B-CLL: response to chemotherapy prior to mobilization predicts the stem cell yieldBone Marrow Transplantation, 1997
- Effect of lym-1 radioimmunoconjugate on refractory chronic lymphocytic leukemiaCancer, 1994
- Pentostatin in Prolymphocytic Leukemia: Phase II Trial of the European Organization for Research and Treatment of Cancer Leukemia Cooperative Study GroupJNCI Journal of the National Cancer Institute, 1993
- Treatment of advanced chronic lymphocytic leukemia by fludarabineAnnals of Hematology, 1991
- Pentostatin in Refractory Chronic Lymphocytic Leukemia: A Phase II Trial of the European Organization for Research and Treatment of CancerJNCI Journal of the National Cancer Institute, 1990
- Lasting Remissions in Hairy-Cell Leukemia Induced by a Single Infusion of 2-ChlorodeoxyadenosineNew England Journal of Medicine, 1990
- Prognostic factors in chronic lymphocytic leukaemia: the importance of age, sex and response to treatment in survivalBritish Journal of Haematology, 1989
- Intravenous Immunoglobulin for the Prevention of Infection in Chronic Lymphocytic LeukemiaNew England Journal of Medicine, 1988
- Combination Chemotherapy with the M-2 Protocol (BCNU, Cyclophosphamide, Vincristine, Melphalan, and Prednisone) for Chronic Lymphocytic Leukemia (Stages III and IV)Oncology, 1985
- Deoxycoformycin-induced response in chronic lymphocytic leukaemia: deoxyadenosine toxicity in non-replicating lymphocytesBritish Journal of Haematology, 1982